Opinion: Why would anyone think a rigorous clinical trial is a bad idea?
In his most recent column, Joe Schwarcz wondered, “How could homoeopathy help with ADHD?” (The Right Chemistry, Feb. 21).
Why would anyone think a rigorous clinical trial is a bad idea?
Schwarcz questions the value of conducting research about the use of homeopathic therapy to treat Attention Deficit Hyperactivity Disorder (ADHD).
Our study — one of the most rigorous studies of homoeopathy to date — is being conducted because patients are using homoeopathy to treat ADHD. Previous studies on this topic have produced varying results and have been criticized for methodological flaws.
We are studying this topic for the same reason most scientists conduct studies: to discover the truth, or at least to get closer to it. As a scientist, I am committed to conducting high-quality studies that help patients and clinicians make evidence-informed choices about a wide range of popular products and therapies, and this study is no different.
View original post 438 more words
- Posted in: Uncategorized